Testosterone: Physiology, regulation, evidence-based roles in energy, circulation, and clinical evaluation

Testosterone is the principal androgen in men and a key steroid hormone in women, synthesized primarily by Leydig cells in the testes and the adrenal glands, with peripheral conversion from precursors in other tissues. It is transported in blood bound mainly to sex hormone-binding globulin (SHBG) and albumin, with a smaller fraction circulating as free testosterone, which is considered biologically available. Testosterone’s effects are mediated through intracellular androgen receptors (AR). After testosterone binds AR, the complex translocates to the nucleus, altering transcription of genes involved in muscle protein synthesis, erythropoiesis, libido, and multiple aspects of vascular function.

Physiologically, testosterone production is regulated by the hypothalamic-pituitary-gonadal axis. Gonadotropin-releasing hormone (GnRH) from the hypothalamus stimulates pituitary luteinizing hormone (LH), which then drives Leydig cell steroidogenesis. This system is governed by negative feedback: rising testosterone suppresses GnRH and LH, stabilizing hormone levels. Circulating testosterone exhibits diurnal variation and declines gradually with age, but clinically meaningful reductions should be distinguished from normal aging and transient changes due to illness, sleep disruption, caloric deficit, or medication effects.

Regarding energy, testosterone influences several mechanisms that can affect perceived vitality. It modulates body composition by promoting lean mass and reducing fat mass, indirectly supporting resting metabolic rate and physical performance. Testosterone also affects neuromuscular function and recovery capacity, which can translate into improved energy and reduced fatigue in individuals with true hypogonadism. At the cellular level, androgen signaling can influence mitochondrial function and oxidative metabolism, though the magnitude of these effects varies across study designs and populations. Additionally, androgen deficiency is associated with mood and motivational changes in some patients; low testosterone correlates with depressive symptoms, decreased sexual desire, and reduced cognitive drive, but causality and directionality are complex and bidirectional with psychosocial factors.

Concerning circulation, testosterone has been linked to vascular homeostasis and erythropoiesis. Androgen signaling can stimulate red blood cell production through increased erythropoietin sensitivity, raising hemoglobin/hematocrit in some contexts. In parallel, testosterone can modulate endothelial function by influencing nitric oxide bioavailability and vascular smooth muscle tone. Observational studies have reported associations between lower testosterone and increased cardiovascular risk markers, while randomized trials have produced mixed outcomes, emphasizing that “circulation support” is not synonymous with cardiovascular disease prevention. Importantly, supraphysiologic testosterone exposure may increase adverse events in selected individuals, underscoring the need for appropriate diagnosis and monitoring.

A key clinical concept is distinguishing symptomatic androgen deficiency from nonspecific fatigue or general “low energy” states. Common symptoms include reduced libido, erectile dysfunction, diminished morning erections, infertility, decreased muscle mass, increased body fat, anemia-like features, and sometimes depressed mood. However, these symptoms overlap with thyroid disorders, sleep apnea, depression, chronic kidney disease, and medication effects. Therefore, evaluation should be structured. Guidelines generally recommend measuring early-morning total testosterone on at least two separate occasions, preferably between 7:00 and 10:00 AM, using reliable assays. If results are borderline or SHBG is abnormal, free testosterone or calculated free testosterone may be assessed. Concomitant testing often includes LH and follicle-stimulating hormone (FSH) to localize primary versus secondary hypogonadism, prolactin when secondary causes are suspected, and additional labs such as CBC, SHBG, and metabolic markers.

Treatment decisions depend on etiology and risk profile. For men with confirmed hypogonadism, testosterone replacement therapy (TRT) can improve libido, sexual function, lean mass, and sometimes anemia. Forms include transdermal gels/patches, intramuscular injections, and other regulated formulations. TRT requires careful surveillance: hematocrit (to detect erythrocytosis), prostate health assessment per age and risk, cardiovascular status evaluation, and monitoring of symptom response. In younger men desiring fertility, TRT can suppress spermatogenesis by reducing intratesticular testosterone; alternatives such as clomiphene or human chorionic gonadotropin may be considered under specialist care.

Any discussion of “drinks” marketed for boosting testosterone or improving energy should be interpreted cautiously. Most food or supplement products have limited evidence for producing clinically significant changes in testosterone levels or measurable improvements in circulation-related outcomes. When products claim “support,” they often rely on general wellness ingredients, proprietary blends, or compounds with weak or inconsistent data. The biologic plausibility of a beverage is insufficient without robust randomized controlled trials showing changes in serum testosterone, free testosterone, SHBG, LH/FSH, or validated endpoints like fatigue scales, endothelial function, blood pressure, or confirmed cardiovascular outcomes. Individuals with untreated hypogonadism, polycythemia, suspected prostate disease, uncontrolled sleep apnea, or significant cardiovascular disease should avoid self-treatment and seek medical assessment.

In summary, testosterone is a tightly regulated androgen hormone with meaningful roles in energy-related function, body composition, mood, erythropoiesis, and aspects of vascular physiology. “Circulation support” is best understood as potential downstream effects on hemoglobin and endothelial function, not as a guarantee of improved cardiovascular health. Evidence-based management requires diagnostic confirmation, identification of cause, and monitored therapy where indicated rather than reliance on unverified supplement claims. Source: @TestDoctor_